Uploaded May 2025 | Updated September 2026, 2 weeks ago
In this episode, Ari Siggaard Knoph talks about the journey to open source at Novo Nordisk – why it started, how internal packages evolved, and what it means for the pharma industry. Learn how the shift from SAS to R improved FDA submissions, made workflows more efficient, and expanded access to new talent.
Click the episode link right above the description to hear the full story.
In this episode, Ari Siggaard Knoph talks about the journey to open source at Novo Nordisk – why it started, how internal packages evolved, and what it means for the pharma industry. Learn how the shift from SAS to R improved FDA submissions, made workflows more efficient, and expanded access to new talent.
Click the episode link right above the description to hear the full story.
